SCHEMBL5024744

SCHEMBL5024744

COC(Cc1ccc(OCC(=O)OC(C)(C)C)cc1)C(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.47
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
PPARG P37231 7/20 0.43
PPARA Q07869 7/20 0.43
PPARD Q03181 6/20 0.43
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42
HDAC8 Q9BY41 1/20 0.41
ITGB3 P05106 1/20 0.40
ITGA2B P08514 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
LTA4H P09960 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5024741 1.00 PTPN1 (0.47) PTPN1MEN1KMT2AALDH1A1LMNA
SCHEMBL5363966 0.90 PTPN1 (0.45) PTPN1MEN1KMT2APPARGPPARA
SCHEMBL14854834 0.86 PLA2G4B (0.44) PTPN1MEN1KMT2AALDH1A1LMNA
SCHEMBL6698814 0.86 PTPN1 (0.47) PTPN1MEN1KMT2AALDH1A1LMNA
SCHEMBL5357749 0.85 ITGB1 (0.43) PTPN1MEN1KMT2AALDH1A1LMNA
SCHEMBL8763598 0.85 PTPN1 (0.47) PTPN1MEN1KMT2AALDH1A1LMNA
SCHEMBL7298611 0.85 PTPN1 (0.47) PTPN1MEN1KMT2AALDH1A1LMNA
SCHEMBL14855324 0.84 PTGS2 (0.44) PTPN1LMNAPPARGPPARANPC1
SCHEMBL6701409 0.84 KMT2A (0.45) PTPN1MEN1KMT2AALDH1A1LMNA
SCHEMBL14285180 0.82 PPARA (0.51) MEN1KMT2AALDH1A1LMNAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7321056-B2 Selective peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2008-01-22 US disclosed
EP-1697306-B1 SELECTIVE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2007-07-25 EP disclosed
US-20070066683-A1 Selective peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY 2007-03-22 US disclosed
EP-1697306-A1 SELECTIVE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2006-09-06 EP disclosed
WO-2005061441-A1 SELECTIVE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2005-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066683-A1 Selective peroxisome proliferator activated receptor modulators PPARG, PPARD, PPARA PTPN1 1763/4885MEN1 4850/4885KMT2A 3261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.